Silencing LINC00857 alleviated the proliferative capacity and facilitated the apoptosis, autophagy and radiotherapy sensitivity of lung cancer cells, suggesting that LINC00857 could act as a potential therapeutic target for LUAD (Han et al., 2020; Su et al., 2020). This evidence concerns the gene LINC00857 and lung cancer.